Bispecific antibodies (BsAbs) represent a groundbreaking advancement in biopharmaceuticals, designed to simultaneously bind two different antigens or epitopes. This dual-targeting capability enhances their therapeutic potential, enabling unique mechanisms of action that are unattainable with conventional monoclonal antibodies. BsAbs are increasingly recognized for their role in oncology,...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian